Summary & Overview

CPT 0556U: Respiratory Pathogen PCR Panel (HealthTrackRx)

CPT code 0556U designates a Proprietary Laboratory Analyses (PLA) test — specifically the HealthTrackRx respiratory pathogen panel from Thermo Fisher Scientific. The assay uses real-time PCR with a reverse transcription step to detect DNA or RNA from up to 12 bacterial and viral respiratory pathogens on a nasal or throat swab. PLA codes like 0556U are unique to a single manufacturer or laboratory, which matters for payer coverage, lab contracting, and reporting. Nationally, molecular respiratory testing remains central to infectious disease surveillance, treatment decisions, and outpatient care pathways.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical application of the test, the service setting, and payer considerations affecting coverage and billing. The publication outlines benchmark topics such as common reimbursement frameworks for PLA codes, coding and billing practice implications for laboratories and providers, and the clinical context for ordering a multi-pathogen respiratory PCR with RT. Data limitations: Data not available in the input for specific coverage policies, negotiated rates, associated taxonomies, ICD-10 diagnoses, and related codes.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare0556UCPTProprietary Laboratory Analysesrespiratory pathogen panelmolecular diagnosticsreal-time PCRRT-PCRclinical laboratoryoutpatient testing

Billing Code Overview

CPT code 0556U is a Proprietary Laboratory Analyses (PLA) code that applies exclusively to the HealthTrackRx test from Thermo Fisher Scientific. The assay detects bacterial and viral pathogens in the respiratory tract using real-time polymerase chain reaction (PCR) with a reverse transcription step to convert RNA into DNA, allowing RNA viruses to be analyzed. The test evaluates up to 12 distinct pathogens and reports each result as either detected or not detected. The specimen is collected via a nasal or throat swab.

Service type: Molecular diagnostic respiratory pathogen panel (real-time PCR with RT step)

Typical site of service: Clinical laboratory or outpatient specimen collection site (nasal/throat swab collection)

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult or pediatric outpatient presenting to a primary care clinic, urgent care, emergency department, or community testing site with acute respiratory symptoms such as cough, sore throat, nasal congestion, fever, or shortness of breath. A clinician obtains a nasopharyngeal, nasal mid-turbinate, anterior nasal, or oropharyngeal swab and orders the proprietary HealthTrackRx test (0556U) from Thermo Fisher Scientific to detect a panel of viral and bacterial respiratory pathogens. The specimen is sent to the performing laboratory where RNA viruses are subjected to reverse transcription followed by real-time PCR to detect target nucleic acids. Results are reported as “detected” or “not detected” for each of the 12 pathogens. Typical workflow steps include patient evaluation, specimen collection, labeling and transport to the reference laboratory, PCR testing with reverse transcription as required, result verification, and clinician notification for treatment or infection control decisions. Typical sites of service include outpatient clinics, urgent care centers, emergency departments, and reference laboratories performing high-complexity molecular testing.

Coding Specifications

Modifier	Description	When to Use
`00`	Procedure has not been modified	Use when no modifier is required and the service was performed under routine circumstances.

Taxonomy Code	Specialty	Notes
207Q00000X	Infectious Disease	Clinical oversight of complex infectious disease diagnosis and interpretation.
2080P0003X	Clinical Pathology	Laboratory medical director and test interpretation responsibilities.
207L00000X	Pediatrics	Ordering and interpretation for pediatric patients with respiratory illness.
208000000X	Diagnostic Laboratory	Performing laboratory personnel and high-complexity molecular testing.
208D00000X	Emergency Medicine	Ordering in emergency department settings for acutely ill patients.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J02.9`	Acute pharyngitis, unspecified	Common presentation prompting testing for viral or bacterial respiratory pathogens.
`J06.9`	Acute upper respiratory infection, unspecified	Broad indication for multiplex respiratory pathogen testing.
`J20.9`	Acute bronchitis, unspecified	Lower respiratory symptoms where pathogen identification can inform management.
`J18.9`	Pneumonia, unspecified organism	Severe respiratory infection where molecular identification may guide therapy or infection control.
`R05`	Cough	Symptom code often used when ordering diagnostic respiratory testing.
`R50.9`	Fever, unspecified	Systemic sign prompting evaluation for respiratory infectious etiologies.
`B34.9`	Viral infection, unspecified	When a viral respiratory infection is suspected and multiplex PCR is appropriate.
`U07.1`	COVID-19	Respiratory viral testing panels may include SARS-CoV-2 targets and are used in diagnosis and surveillance.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87631`	Infectious agent detection by nucleic acid (DNA or RNA); respiratory syncytial virus, amplified probe technique	May be performed as an alternative single-target molecular test when RSV is specifically suspected instead of a multi-pathogen panel.
`87632`	Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, amplified probe technique	May be ordered when influenza testing is needed separately or rapidly in addition to or instead of a multiplex panel.
`87070`	Culture, bacterial, any material, with isolation and presumptive identification of isolates	May be ordered if bacterial culture is required for pathogens where culture-based identification or susceptibility testing is clinically indicated after molecular detection.
`87804`	Infectious agent antigen detection by immunoassay with direct optical observation; influenza	Rapid antigen tests may be performed at point of care while the molecular panel is sent to reference lab for comprehensive analysis.
`99000`	Handling and/or conveyance of specimen for transfer from site of collection to laboratory	Used by some entities to report specimen pickup/transport logistics when applicable and allowed by payers.